| ||
Healthcare and pharmaceutical industry stimulating demand for hiring talent Economic Times Where global market slowdown has affected the major employment generators such as IT/Telecom, BFSi and ITeS, Healthcare/Pharmaceutical sector reported enhanced hiring activity during the first half of 2012, reveals TimesJobs.com Bi-annual RecruiteX. See all stories on this topic » | ||
NextWave Pharmaceuticals Receives FDA Approval of Quillivant XR™ for Once ... Sacramento Bee CUPERTINO, Calif., Oct. 1, 2012 -- /PRNewswire/ -- NextWave Pharmaceuticals, an emerging specialty pharmaceutical company, announced FDA approval of Quillivant XR™ (methylphenidate hydrochloride) for extended-release oral suspension, CII. See all stories on this topic » | ||
Elder Pharmaceuticals shareholders approved 30% final dividend Equity Bulls Managing Director Mr. Alok Saxena said the Company's endeavor has always been to be a leading innovator of pharmaceutical products while maintaining a high standard of quality controls and overall integrity of the brand. He remains positive of the ... See all stories on this topic » | ||
| ||
KAKETSUKEN Becomes First Japanese Pharmaceutical Company to Implement ... National Post KAKETSUKEN Becomes First Japanese Pharmaceutical Company to Implement Medidata's Integrated Solutions for Randomization, Trial Supply Management and Clinical Data Collection, Management and Reporting in Japanese Trials. Twitter · Google+ ... See all stories on this topic » | ||
NIPER organises seminar on "environment, hazard & waste management in ... pharmabiz.com The National Institute of Pharmaceutical Education & Research (NIPER), Mohali recently oragnised a seminar on "environment, hazard & waste management in pharmaceutical industries'. In the seminar it was stressed that the small and medium industries ... See all stories on this topic » | ||
Colby Pharmaceutical Announces SBIR Award for JunD Oncoprotein-Androgen ... The Herald | HeraldOnline.com Colby Pharmaceutical Announces SBIR Award for JunD Oncoprotein-Androgen Receptor (AR) Interaction Inhibitor Drugs in Novel Prostate Cancer Therapy. Published: October 1, 2012 Updated 7 minutes ago. 2012-10-01T13:17:44Z. Tweet · 0 Comments ... See all stories on this topic » | ||
Packaging pharmaceuticals: Bridging the science of medicine and the science of ... Bizcommunity.com When contemplating the pharmaceutical industry, it is easy to understand how the average Joe could be overwhelmed by scientific speak, legislative parameters, dosage information, allergy warnings, prohibitive costs, new affordable generic options ... See all stories on this topic » | ||
Reforms revive Q2 fortunes of Gujarat-based stocks Daily News & Analysis JRVyas-promoted pharma major, Dishman Pharmaceuticals has given one of the highest returns during the period. It increased by 48%, followed by Claris Lifesciences (38%), Torrent Pharmaceuticals (15.80%) and Cadila Healthcare which was up 13.13%. See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment